Showing results (51-60 of 104) with videos related to
Sort By:
Pageof 11
European Urology|December 23, 2011
Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancerRobert Rosenblatt, Amir Sherif, Erkki Rintala, et al.Acta Oncologica (Stockholm, Sweden)|December 23, 2014
A template for writing radiotherapy protocolsPer Nilsson, Crister Ceberg, Elisabeth Kjellén, et al.Acta Oncologica (Stockholm, Sweden)|September 17, 2005
Additive/synergistic antitumoral effects on prostate cancer cells in vitro following treatment with a combination of docetaxel and zoledronic acidAnders Ullén, Lena Lennartsson, Ulrika Harmenberg, et al.Anticancer Research|December 7, 2016
Bone-targeted Novel Cytotoxic Polybisphosphonate Conjugate in Castration-resistant Prostate Cancer: A Multicenter Phase 1 StudyCamilla Thellenberg-Karlsson, Claes Nyman, Sten Nilsson, et al.Acta Oncologica (Stockholm, Sweden)|September 20, 2006
A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinomaChrister Svedman, Per Sandström, Pavel Pisa, et al.International Journal of Oncology|March 29, 2007
Somatostatin effects on the proteome of the LNCaP cell-lineZhaoxu Liu, Sofia Bengtsson, Morten Krogh, et al.Acta Oncologica (Stockholm, Sweden)|September 9, 2021
High rate of local control and cure at 10 years after treatment of prostate cancer with external beam radiotherapy and high-dose-rate brachytherapy: a single centre experienceMarie Hjälm-Eriksson, Sten Nilsson, Yvonne Brandberg, et al.Investigational New Drugs|August 9, 2023
Cytotoxicity of poly-guanidine in medulloblastoma cell linesGabriel Gallo-Oller, Teresita Díaz de Ståhl, Ayodele Alaiya, et al.Acta Oncologica (Stockholm, Sweden)|August 25, 2005
Prostate cancer cell lines lack amplification: overexpression of HER2Anders Ullén, Lena Lennartsson, Ulrika Harmenberg, et al.Plos One|January 6, 2016
Improving the Prediction of Prostate Cancer Overall Survival by Supplementing Readily Available Clinical Data with Gene Expression Levels of IGFBP3 and F3 in Formalin-Fixed Paraffin Embedded Core Needle Biopsy MaterialZhuochun Peng, Karl Andersson, Johan Lindholm, et al.Pageof 11